Hls Therapeutics Inc opened trading today at $4.75 and closed at $4.73. prices ranged from a low of $4.72 to a high of $4.75.

Shares eased -0.42 percent from the previous day's close of $4.75.

Today across North America, the TSX Composite closed 0.05% at 21885.38, the S&P 500 closed 0.02% at 5071.63, the Dow Jones Industrial Average closed -0.11% at 38460.92 and the Nasdaq Composite closed 0.10% at 15712.75.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

Trading volume was 4,512 on 21 total trades. On average, Hls Therapeutics Inc has traded 3,073 shares in the last five days and 9,501 year-to-date.

Trading across the entire TSX saw 1,786 price advancers against 3,411 declines and 112 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, the shares have dipped -20.50 percent in 52 weeks, while in 2024, they have boosted 19.75%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $151.46 million on a float of 31,886 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Currently, Hls Therapeutics Inc's consensus rating is "Moderate Buy" based on 5 analysts according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..